CSIMarket
 


Brainstorm Cell Therapeutics inc   (BCLI)
Other Ticker:  
 


Brainstorm Cell Therapeutics Inc 's ROA from the third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Brainstorm Cell Therapeutics Inc 's ROA in the third quarter of 2023?
Brainstorm Cell Therapeutics Inc recorded a cumulative net loss of $-17 million during 12 months ending in the third quarter of 2023, resulting in a negative return on assets (ROA) of -239.72%.

However, within the Healthcare sector 980 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2023 quarter, so far to 4709, from total ROA ranking in the second quarter of 2023 at 4993.

What is ROA?


Return On Assets (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Total Assets Change -57.13 % -69.6 % -69.02 % -71.13 % -61.62 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -17 -22 -24 -24 -25
Return On Assets (TTM) -239.72 % -252.11 % -197.81 % -147.09 % -117.21 %
BCLI's Total Ranking # 4709 # 4993 # 5102 # 5675 # 5108
Total Assets (TTM) in million 6 6 8 8 13
Seq. Total Assets Change -1.13 % -26.99 % -6.85 % -36.24 % -29.89 %
Seq. Net Income Change - - - - -



Return On Assets Company Ranking
Within: No.
Industry # 159
Sector # 981
Overall # 4690

Return On Assets Statistics
High Average Low
-49.78 %
-130.04 %
-265.29 %
(Dec 31 2017)   (Dec 31 2019)





Financial Statements
Brainstorm Cell Therapeutics Inc 's Assets $ 6 million BCLI's Balance sheet
Brainstorm Cell Therapeutics Inc 's Income $ -1 million Quarterly BCLI's Income Statement
BCLI's Income by Division See BCLI's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
(Dec 31 2020)
FY 2020
(Dec 31 2019)
FY 2019
(Dec 31 2018)
FY 2018
Y / Y Total Assets Change -71.13 % -42.88 % 684.5 % -41.81 % -1.71 %
Total Assets in million 8 29 51 7 11
Y / Y Net Income Change - - - - -
Net Income in million -24 -24 -32 -23 -14
Return On Assets -287.27 % -83.54 % -62.06 % -355.88 % -124.23 %




More Return On Assets Ratios
BCLI's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BCLI's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Roa for BCLI's Competitors
Roa for Brainstorm Cell Therapeutics Inc 's Suppliers
Return On Assets for BCLI's Customers

You may also want to know
BCLI's Roi BCLI's Inventory Turnover Ratio BCLI's Growth Rates BCLI's Dividend Comparisons
BCLI's Profitability Ratios BCLI's Asset Turnover Ratio BCLI's Dividend Growth
BCLI's Roe BCLI's Valuation Ratios BCLI's Financial Strength Ratios BCLI's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2023, within Healthcare Sector ROA


Date modified: 2023-11-16T14:26:41+00:00


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com